Abstract
Purpose
The incidence of Acute invasive fungal rhinosinusitis (AIFRS) is on the rise considering the multitude of comorbidities present in a single patient.The delay in suspecting the fungal etiology, presentation of the patient for an Otorhinolaryngology consult and lack of defined protocols affects outcome.This study looks in to the various aspects of treatment of AIFRS including sample collection, diagnosis and medicosurgical treatment. We propose a protocol for the management of these patients crafted from our outcome.
Methods
Between September 2015–September 2017, 14 patients presented with AIFRS. Targeted samples were taken for Potassium hydroxide mount, histopathological studies and fungal culture. Management was initiated with antifungals and multi-approach surgical debridement.
Results
Six of these patients had multiple comorbidities and most were uncontrolled diabetics. The average delay in presentation was 9 days. Potassium hydroxide mount was the screening test of choice. A minimum of two sittings of debridement was essential. In an average follow-up period of 15.12 months, all the patients are alive and disease free.
Conclusion
A high index of suspicion, awareness among medical fraternity and precise sample collection aids a firm diagnosis. Simultaneous initiation of surgical debridement and anti-fungals is fundamental.
Similar content being viewed by others
Abbreviations
- AIFRS:
-
Acute invasive fungal rhinosinusitis
- AmB:
-
Amphotericin B
- AE:
-
Anterior ethmoidotomy
- BA:
-
Bronchial asthma
- CKD:
-
Chronic kidney disease
- CT:
-
Computerized tomography
- DKA:
-
Diabetic ketoacidosis
- DNE:
-
Diagnostic nasal endoscopy
- FS:
-
Frontal sinus
- FESS:
-
Functional endoscopic sinus surgery
- HPE:
-
Histopathological examination
- HTN:
-
Hypertension
- IT:
-
Inferior turbinate
- IHD:
-
Ischemic heart disease
- LP:
-
Lamina papyracea
- Lip AmB:
-
Liposomal amphotericin B
- MS:
-
Maxillary sinus
- MMA:
-
Middle meatal antrostomy
- MT:
-
Middle turbinate
- MPGN:
-
Membranoproliferative glomerulonephritis
- NLD:
-
Nasolacrimal duct
- Pin :
-
Posaconazole
- PE:
-
Posterior ethmoidotomy
- KOH mount:
-
Potassium hydroxide mount
- T1DM:
-
Type 1 diabetes mellitus
- T2DM:
-
Type 2 diabetes mellitus
- ST:
-
Superior turbinate
- V:
-
Voricanazole
References
Spielberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS (2009) Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 48(12):1743–1751. https://doi.org/10.1086/599105
Payne SJ, Mitzner R, Kunchala S, Roland L, McGinn JD (2016) Acute invasive fungal rhino sinusitis: a 15-year experience with 41 patients. Otolaryngol Head Neck Surg 154(4):759–764
Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B (2010) Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg 143:614–620
Monroe MM, McLean M, Sautter N, Wax MK, Andersen PE, Smith TL, Gross ND (2013) Invasive fungal rhino sinusitis: a 15 year experience with 29 patients. The Laryngoscope 123:1583–1587
Turner JH, Soudry E, Nayak JV, Hwang PH (2013) Survival outcomes in acute invasive fungal sinusitis; a systematic review and quantitative synthesis of published evidence. The Laryngoscope 123:1112–1118
Kolekar JS (2015) Rhinocerebral mucormycosis: a retrospective study. Indian J Otolaryngol Head Neck Surg 67:93–96
Bala K, Chander J, Handa U, Punia RS, Attri AK (2015) A prospective study of mucormycosis in north India: Experience from a tertiary care hospital. Med Mycol 53:248–257
Richardson MD, Kahkola PK, Shankland GS (2003) Rhizopus, rhizomucor, absidia, and other agents of systemic and subcutaneous zygomycoses. In: Murray PR, Baron EJ, Jorgensen JH et al (eds) Manual of clinical microbiology. ASM Press, Washington, DC, pp 1761–1780
Mahomeda S, Basanth S, Mlisana K (2015) The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus. IDCases 2:116–117
Akdag M, Bozkurt F, Alabalik U, Hattapoglu S, Ramazan GUN (2014) Does affect combination of surgery with antifungal therapy prolong life in a mucormycosis of sino-nasal? A case report. Int Arch Med Res 6(2):26–35
Kaazak E, Aslan E, Akalin H, Saraydaroglu O, Hakyemez B, Erisen L (2013) A Mucormycosis case treated with combination of capsofungin and amphotericin B. J Mycale Med 23:179–184
Parikh SL, Venkatraman G, DelGaudio JM (2004) Invasive fungal sinusitis: a 15-year review from a single institution. Am J Rhinol 18(2):75–81
Cho H-J, Jang M-S, Hong SD, Chung S-K, Kim HY, Dhong H-J (2015) Prognostic factors for survival in patients with acute invasive fungal rhino sinusitis. Am J Rhinol Allergy 29(1):48–53
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We have no conflicts of interest to declare.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and or national research committee and with 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
This was a retrospective chart review and thus informed consent was not required by our human ethics board.
Rights and permissions
About this article
Cite this article
Shanbag, R., Rajan, N.R. & Kumar, A. Acute invasive fungal rhinosinusitis: our 2 year experience and outcome analysis. Eur Arch Otorhinolaryngol 276, 1081–1087 (2019). https://doi.org/10.1007/s00405-019-05288-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-019-05288-w